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Supplemental Figure ledgends: 
Supplemental Figure 1. PAGE4 expression in prostate cells. mRNA expression of PAGE4 was 
detected by RT-PCR in prostate cancer cells (PC-3, DU-145, LNCaP, LN96, CWR22rv1, 
LAPC4), BPH cells (267B1, BRF55, BPH-1), normal prostate cells (PrEC), normal prostate 
stromal cells (PrSc), and human embryonic kidney cells (HEK-293T). Values are expressed 
relative to the expression of TATA box binding protein (TBP) mRNA. Data are represented as 
mean ± SD.   
Supplemental Figure 2. siRNA transfection efficacy in tested cells. (A), mRNA levels of 
PAGE4 were detected by RT-PCR 48 h after PAGE4 SMARTpool siRNA transfection in 
LNCaP, LN96, CWR22rv1, HEK-293T, and BRF55 cells. Data are represented as mean ± SD. 
(B), LNCaP cells were transfected with pCMV6-empty or pCMV6-PAGE4-DDK vector. 
Alternately, PAGE4 SMARTpool siRNA or scrambled siRNA was given following pCMV6-
PAGE4-DDK transfection. PAGE4 protein tagged with DDK was detected by anti-DDK (Flag) 
antibody.  
Supplemental Figure 3. Effect of PAGE4 siRNA. (A) and (D), BRF55, HEK-293T, PC-3, and 
LAPC4 cells were transfected with 50nM PAGE4 SMARTpool siRNA. Cell viability was 
evaluated by WST-1 assay on one through seven days after transfection. (B), LNCaP cells was 
transfected with 2 to 50nM PAGE4 SMARTpool siRNA. Cell viability was evaluated by WST-1 
assay 3 days after transfection. (C), LNCaP cells was transfected with PAGE4 SMARTpool 
siRNA or four individual siRNAs composing SMARTpool siRNA. Cell viability was evaluated 
by WST-1 assay 5 days after transfection. All experiments were biological replicates repeated a 
minimum of three times. *, P < 0.05 in comparison to scrambled-siRNA; #, P < 0.05 in 
comparison to normal controls without any treatment. 
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Supplemental Table 1. Amino acid composition of PAGE4 protein. 
Polar residue % Non-polar residue % 
Q 6.9 V 5.9 
S 5.9 L 1 
P 10.8 M 2 
E 14.7 F 1 
K 6.9 W 0 
R 7.8 Y 0 
 
 
